Variability in Liver Biopsy Assessment: Data from the Pegozafermin Phase 1b/2a Study in Subjects with Non-Alcoholic Steatohepatitis (NASH)

Written by Admin | Nov 8, 2022 5:00:00 AM

Study Background

The objective of the study was to assess the impact on histological endpoints in the Phase 1b/2a POC study of assessment by 4 individual expert NASH pathologists. Loomba et al.

View full post